Compare NBIX & AFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBIX | AFG |
|---|---|---|
| Founded | 1992 | 1872 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 11.7B |
| IPO Year | 1996 | 1997 |
| Metric | NBIX | AFG |
|---|---|---|
| Price | $152.72 | $146.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 22 | 4 |
| Target Price | ★ $180.91 | $141.00 |
| AVG Volume (30 Days) | ★ 1.4M | 335.3K |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.72% |
| EPS Growth | ★ 41.95 | N/A |
| EPS | 3.30 | ★ 5.28 |
| Revenue | $161,626,000.00 | ★ $8,174,000,000.00 |
| Revenue This Year | $24.73 | N/A |
| Revenue Next Year | $13.14 | $4.44 |
| P/E Ratio | $45.72 | ★ $27.59 |
| Revenue Growth | ★ 977.51 | N/A |
| 52 Week Low | $122.14 | $123.09 |
| 52 Week High | $186.12 | $150.02 |
| Indicator | NBIX | AFG |
|---|---|---|
| Relative Strength Index (RSI) | 34.68 | 60.29 |
| Support Level | $125.85 | $127.67 |
| Resistance Level | $160.08 | $146.13 |
| Average True Range (ATR) | 6.42 | 2.50 |
| MACD | -2.47 | 0.02 |
| Stochastic Oscillator | 9.54 | 76.55 |
Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.
American Financial Group Inc is an insurance holding company. Through its subsidiaries, it is engaged in the property and casualty insurance business, focusing on specialized commercial products for businesses. The group operates through two segments: Property and Casualty Insurance, which generates maximum revenue, and Other. The Property and Casualty Insurance segment is further divided into different sub-segments, such as Property and transportation, Specialty casualty, and Specialty financial. These sub-segments offer insurance coverage for vehicles and commercial property, customized programs for small to mid-sized businesses, workers' compensation insurance, risk management insurance programs for lending and leasing institutions, trade credit insurance, and other insurance products.